Sutro Biopharma (STRO) Total Current Liabilities (2017 - 2025)
Historic Total Current Liabilities for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to $71.9 million.
- Sutro Biopharma's Total Current Liabilities fell 4524.0% to $71.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.9 million, marking a year-over-year decrease of 4524.0%. This contributed to the annual value of $131.9 million for FY2024, which is 4069.19% up from last year.
- Per Sutro Biopharma's latest filing, its Total Current Liabilities stood at $71.9 million for Q3 2025, which was down 4524.0% from $74.2 million recorded in Q2 2025.
- Sutro Biopharma's Total Current Liabilities' 5-year high stood at $133.0 million during Q1 2025, with a 5-year trough of $22.7 million in Q1 2021.
- For the 5-year period, Sutro Biopharma's Total Current Liabilities averaged around $72.6 million, with its median value being $67.1 million (2023).
- Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 9364.62% in 2024, then tumbled by 4524.0% in 2025.
- Sutro Biopharma's Total Current Liabilities (Quarter) stood at $41.7 million in 2021, then surged by 59.45% to $66.5 million in 2022, then skyrocketed by 40.87% to $93.7 million in 2023, then soared by 40.69% to $131.9 million in 2024, then crashed by 45.49% to $71.9 million in 2025.
- Its Total Current Liabilities stands at $71.9 million for Q3 2025, versus $74.2 million for Q2 2025 and $133.0 million for Q1 2025.